Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mario Cazzola, Paola Rogliani, Lucia Novelli & Maria Gabriella Matera. (2013) Inhaled corticosteroids for chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:18, pages 2489-2499.
Read now
Read now
Sukhwinder Singh Sohal, Chris Ward, Wan Danial, Richard Wood-Baker & Eugene Haydn Walters. (2013) Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 7:3, pages 275-288.
Read now
Read now
Articles from other publishers (17)
Md Sadique Hussain, Parvarish Sharma, Daljeet Singh Dhanjal, Navneet Khurana, Manish Vyas, Neha Sharma, Meenu Mehta, Murtaza M. Tambuwala, Saurabh Satija, Sukhwinder Singh Sohal, Brian.G.G. Oliver & Hari S. Sharma. (2021) Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. Chemico-Biological Interactions 348, pages 109637.
Crossref
Crossref
Alessandro Marcon, Francesca Locatelli, Dirk Keidel, Anna B Beckmeyer-Borowko, Isa Cerveri, Shyamali C Dharmage, Elaine Fuertes, Judith Garcia-Aymerich, Joachim Heinrich, Medea Imboden, Christer Janson, Ane Johannessen, Bénédicte Leynaert, Silvia Pascual Erquicia, Giancarlo Pesce, Emmanuel Schaffner, Cecilie Svanes, Isabel Urrutia, Deborah Jarvis, Nicole M Probst-Hensch & Simone Accordini. (2018) Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study. Thorax 73:9, pages 825-832.
Crossref
Crossref
Thea van den Bosch, Marcel Kwiatkowski, Rainer Bischoff & Frank J Dekker. (2017) Targeting transcription factor lysine acetylation in inflammatory airway diseases. Epigenomics 9:7, pages 1013-1028.
Crossref
Crossref
Thea van den Bosch, Niek G.J. Leus, Hannah Wapenaar, Alexander Boichenko, Jos Hermans, Rainer Bischoff, Hidde J. Haisma & Frank J. Dekker. (2017) A 6-alkylsalicylate histone acetyltransferase inhibitor inhibits histone acetylation and pro-inflammatory gene expression in murine precision-cut lung slices. Pulmonary Pharmacology & Therapeutics 44, pages 88-95.
Crossref
Crossref
Niek G. J. Leus, Thea van den Bosch, Petra E. van der Wouden, Kim Krist, Maria E. Ourailidou, Nikolaos Eleftheriadis, Loes E. M. Kistemaker, Sophie Bos, Rutger A. F. Gjaltema, Solomon A. Mekonnen, Rainer Bischoff, Reinoud Gosens, Hidde J. Haisma & Frank J. Dekker. (2017) HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Scientific Reports 7:1.
Crossref
Crossref
Yuan Lei, Yiping Gao, Jinkun Chen, Miao Li, Xiaomei Wu, Qin Ning, Jianping Zhao, Weining Xiong, Yongjian Xu & Jungang Xie. (2017) GLCCI1 rs37973: a potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese chronic obstructive pulmonary disease patients. Scientific Reports 7:1.
Crossref
Crossref
Seong Yong Lim. 2017. COPD. COPD
219
242
.
I. H. Heijink, M. R. Jonker, M. de Vries, A. J. M. van Oosterhout, E. Telenga, N. H. T. ten Hacken, D. S. Postma & M. van den Berge. (2016) Budesonide and fluticasone propionate differentially affect the airway epithelial barrier. Respiratory Research 17:1.
Crossref
Crossref
Annelies Slats & Christian Taube. (2015) Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?. Therapeutic Advances in Respiratory Disease 10:1, pages 57-71.
Crossref
Crossref
Bing Zhu, Mehra Haghi, Mary Goud, Paul M. Young & Daniela Traini. (2015) The formulation of a pressurized metered dose inhaler containing theophylline for inhalation. European Journal of Pharmaceutical Sciences 76, pages 68-72.
Crossref
Crossref
Stephanie A. Christenson, Katrina Steiling, Maarten van den Berge, Kahkeshan Hijazi, Pieter S. Hiemstra, Dirkje S. Postma, Marc E. Lenburg, Avrum Spira & Prescott G. Woodruff. (2015) Asthma–COPD Overlap. Clinical Relevance of Genomic Signatures of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 191:7, pages 758-766.
Crossref
Crossref
K. Suresh Babu, Jack A. Kastelik & Jaymin B. Morjaria. (2014) Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. British Journal of Clinical Pharmacology 78:2, pages 282-300.
Crossref
Crossref
Maarten van den Berge, Katrina Steiling, Wim Timens, Pieter S Hiemstra, Peter J Sterk, Irene H Heijink, Gang Liu, Yuriy O Alekseyev, Marc E Lenburg, Avrum Spira & Dirkje S Postma. (2014) Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity. Thorax 69:1, pages 14-23.
Crossref
Crossref
Sukhwinder Singh Sohal, David Reid, Amir Soltani, Steven Weston, Hans Konrad Muller, Richard Wood-Baker & Eugene Haydn Walters. (2013) Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized Controlled Trial. PLoS ONE 8:5, pages e64833.
Crossref
Crossref
Abraham B Roos & Magnus Nord. (2012) The emerging role of C/EBPs in glucocorticoid signaling: lessons from the lung. Journal of Endocrinology 212:3, pages 291-305.
Crossref
Crossref
Jose Javier Garcia-Medina, Monica del-Rio-Vellosillo & Manuel Garcia-Medina. (2011) Herpetic Blepharitis and Inhaled Budesonide. Ophthalmology 118:12, pages 2520.e5-2520.e7.
Crossref
Crossref
Rokhsara Rafii, Timothy E. Albertson, Samuel Louie & Andrew L. Chan. (2011) Update on Pharmaceutical and Minimally Invasive Management Strategies for Chronic Obstructive Pulmonary Disease. Pulmonary Medicine 2011, pages 1-11.
Crossref
Crossref